I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Eye Stroke: What It Is and Why It Is a Medical Emergency
Understanding Eye Stroke
Knowing what happens inside the eye during a retinal artery occlusion helps explain why every minute counts. These sections break down the biology of the condition, the different forms it can take, and why acting within the first hours matters so much.
The central retinal artery is the main blood vessel that supplies the inner layers of the retina. When a blockage occurs, it is most often caused by an embolus, a small particle of cholesterol, calcium, or blood clot material that travels from the carotid arteries in the neck or from the heart and lodges within the retinal artery. Once blood flow stops, the retinal ganglion cells, the specialized nerve cells that carry visual signals through the optic nerve to the brain, begin to sustain irreversible damage. These cells are extremely sensitive to oxygen deprivation, and harm begins within minutes of the blockage occurring.
The retina has very little ability to survive without blood flow. Irreversible damage can begin within roughly 90 to 240 minutes of a complete arterial blockage. This narrow window mirrors that of a brain stroke, where tissue also dies rapidly without adequate circulation. Every minute between the onset of vision loss and medical evaluation reduces the realistic options for protecting remaining vision. Patients who act immediately give their care team the best opportunity to assess the situation and intervene.
Retinal artery occlusion is classified based on where in the arterial system the blockage occurs.
- Central retinal artery occlusion (CRAO): The most severe form. The main retinal artery is blocked, affecting blood flow to the entire retina. Vision loss is typically sudden and profound.
- Branch retinal artery occlusion (BRAO): A smaller branch artery is blocked, causing loss of part of the visual field. The prognosis is generally more favorable than CRAO.
- Ophthalmic artery occlusion: The blockage occurs in the artery before it even reaches the retina, cutting off both the retinal and choroidal blood supply. This form often results in the most severe visual loss.
All forms of retinal artery occlusion are medical emergencies that require immediate evaluation, regardless of how much or how little vision has been lost.
Who Is at Risk for an Eye Stroke
Eye stroke shares its root causes with heart disease and brain stroke. Knowing the risk factors can help patients and their physicians stay alert to warning signs and pursue appropriate monitoring before a crisis occurs.
Eye stroke most often affects adults over the age of 60, though it can and does occur in younger individuals. Both men and women are affected. Younger patients who develop retinal artery occlusion are more likely to have an identifiable cardiac source of emboli, a blood clotting disorder called a hypercoagulable state, or an inflammatory vascular condition. No age group is entirely exempt from risk, which makes awareness of the symptoms important at any stage of life.
The medical conditions that raise the risk of heart disease and brain stroke also raise the risk of an eye stroke. The most common contributing factors include the following.
- High blood pressure (hypertension)
- Diabetes mellitus
- High cholesterol (hyperlipidemia)
- Cigarette smoking
- Carotid artery disease, meaning significant narrowing of the arteries in the neck
- Atrial fibrillation, an irregular heart rhythm that can allow clots to form and travel to the eye
- Cardiac valve disease
Many patients who experience a retinal artery occlusion discover during follow-up evaluation that they have one or more of these conditions that had not yet been diagnosed. The eye stroke itself often serves as the first signal that a significant cardiovascular problem exists and needs to be addressed.
Giant cell arteritis is an inflammatory condition affecting medium and large blood vessels that predominantly affects patients over the age of 50. It can cause sudden blockage of the retinal artery and is one of the few identifiable causes of eye stroke that responds directly to targeted medical treatment. Early recognition and treatment with high-dose corticosteroids can protect the other eye from a similar event. For this reason, every patient over 50 who presents with a new retinal artery occlusion is screened for this condition without delay.
Recognizing the Symptoms
The symptoms of an eye stroke are distinctive, but their sudden and painless nature can lead patients to hesitate before seeking help. Understanding what to watch for, including warning episodes that may occur before a full eye stroke, is essential for acting at the right moment.
The defining symptom of an eye stroke is a sudden, painless loss of vision in one eye. In central retinal artery occlusion, the entire visual field of the affected eye may go dark or become severely blurred within seconds. In branch retinal artery occlusion, only a portion of the visual field is lost while other areas may remain intact. The onset is almost always abrupt, and patients can often recall exactly what they were doing when it happened. The absence of pain is notable and sometimes causes patients to wait, hoping the vision will return on its own. It is critically important not to wait.
Some patients experience brief episodes of temporary vision loss before a sustained eye stroke occurs. This is called amaurosis fugax, a term meaning fleeting blindness. During these episodes, vision in one eye dims or disappears for seconds to a few minutes before returning to normal. This happens when an embolus temporarily blocks the retinal artery before breaking apart or moving. These transient episodes are serious warning signs indicating that a full and permanent occlusion may be imminent. Emergency evaluation is necessary even if vision has fully returned by the time the patient reaches care.
When the eye is examined during or shortly after an eye stroke, the retina shows characteristic changes. The inner retinal layers become swollen and pale from the loss of blood flow. In central retinal artery occlusion, a distinctive cherry-red spot appears at the center of the retina (the macula), where the tissue is thin enough for the underlying blood supply to remain visible against the surrounding pale retina. An embolus may sometimes be seen lodged within the retinal artery or one of its branches. The arteries may appear narrow, and the blood column within them may take on a fragmented appearance known as boxcarring. These findings allow a confident clinical diagnosis during an emergency eye examination without extensive testing.
Diagnosing an Eye Stroke
Diagnosis is primarily made through a clinical eye examination, but additional testing plays a critical role in understanding the cause of the occlusion and evaluating the patient's overall vascular health.
The diagnosis of eye stroke is typically confirmed through a dilated eye examination that reveals the characteristic retinal findings. Optical coherence tomography (OCT), a non-invasive imaging scan that produces detailed cross-sectional images of the retina, can show thickening of the inner retinal layers caused by ischemic swelling. Fluorescein angiography, a diagnostic test in which a safe dye is injected into a vein and photographs are taken as it passes through the retinal blood vessels, can demonstrate delayed or absent filling of the arterial circulation. These tests help confirm the diagnosis and define how much of the retina has been affected.
Because retinal artery occlusion is classified as a stroke equivalent, urgent evaluation at a stroke center is an important part of the emergency response. This evaluation typically includes brain imaging to identify any concurrent or recent ischemic changes in the brain, imaging of the carotid arteries to check for significant narrowing, and cardiac evaluation including an echocardiogram (an ultrasound of the heart) and an electrocardiogram (ECG) to assess for arrhythmias or structural abnormalities. Identifying the source of the embolus through this workup is critical for preventing a future brain stroke. Research has documented that a meaningful proportion of patients with central retinal artery occlusion have simultaneous evidence of cerebral ischemia, reinforcing why this evaluation should not be delayed or skipped.
For patients over the age of 50, blood tests measuring erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), two markers of systemic inflammation in the body, are ordered urgently as part of the initial workup. If the results or the clinical picture suggest giant cell arteritis, high-dose corticosteroid treatment is typically started right away, even before a confirmatory biopsy is performed. Prompt treatment can protect the unaffected eye from a similar event, making this an urgent and potentially sight-saving step.
Every patient with a retinal artery occlusion undergoes a thorough cardiovascular risk profile. This includes measuring blood pressure, blood glucose, and cholesterol, and assessing for cardiac arrhythmias that may be generating emboli. Published research involving large patient populations has found that individuals who have had a central retinal artery occlusion carry a significantly elevated risk of ischemic brain stroke compared to the general population. This finding makes comprehensive cardiovascular evaluation and ongoing risk factor management essential components of care, not optional ones.
Treatment for Eye Stroke
Treatment for retinal artery occlusion has two distinct goals: attempting to restore blood flow to the retina as quickly as possible, and addressing the underlying vascular causes to reduce the risk of future events. The two go hand in hand and are pursued simultaneously.
When a patient arrives within the early treatment window, several interventions may be attempted to try to dislodge the embolus or improve circulation to the retina. Ocular massage involves applying intermittent gentle pressure to the eye to vary intraocular pressure (the fluid pressure inside the eye), with the goal of helping to shift the embolus. Medications that rapidly lower intraocular pressure may be given intravenously or through other routes to create favorable conditions for blood flow. Patients may also be asked to breathe into a bag to raise carbon dioxide levels in the blood, which can cause retinal vessels to dilate. These measures have limited and variable effectiveness, but they are attempted in the acute setting because the potential benefit is real and the risks are low.
Thrombolysis is the use of clot-dissolving medication to break up the blockage within the retinal artery. This approach is based on the same principle used in treating acute brain stroke, where thrombolytic agents may be given within a narrow time window to restore blood flow. Clinical trials are actively studying whether intravenous thrombolysis can improve visual outcomes in acute central retinal artery occlusion. Patients who present quickly and meet specific medical criteria may be evaluated for this intervention at a stroke center. Because the time window is short, early presentation is essential for this option to even be considered.
Hyperbaric oxygen therapy involves breathing concentrated oxygen in a pressurized chamber. The elevated oxygen content in the blood may allow the choroidal circulation, the blood supply located just beneath the retina, to partially sustain the retinal tissue while the retinal artery remains blocked. Some published data suggest potential benefit from this therapy even when administered slightly beyond the standard acute window, though the evidence base is still developing and access to hyperbaric facilities varies by location and clinical circumstance.
Regardless of the visual outcome, addressing the underlying cardiovascular conditions that caused the eye stroke is a critical part of treatment. This involves controlling blood pressure, managing blood sugar and cholesterol, and initiating antiplatelet therapy such as aspirin or anticoagulation medications as appropriate for each patient's individual situation. Patients found to have significant carotid artery narrowing may be referred to a vascular specialist for a procedure to reduce stroke risk. Giant cell arteritis, when identified, requires extended corticosteroid therapy under ongoing and close medical supervision.
What to Expect After an Eye Stroke
Recovery from a retinal artery occlusion involves understanding both the realistic visual outlook and the ongoing steps needed to protect overall health. The following sections address prognosis, future vascular risk, and practical adjustment.
The visual outlook after central retinal artery occlusion is generally guarded. A large proportion of patients are left with significantly reduced vision in the affected eye, and meaningful recovery is uncommon even with timely treatment. Branch retinal artery occlusion carries a more favorable prognosis, particularly when the blockage did not affect the central macular region where sharp detail vision originates. Patients who arrive early and receive evaluation within the acute window may have a modestly better chance of some visual recovery, though outcomes vary considerably from person to person. We are committed to being honest and compassionate with our patients about what to realistically expect during this process.
An eye stroke is a serious signal that the cardiovascular system is under stress. Patients with a history of retinal artery occlusion face an elevated risk of future brain stroke and heart attack. Following prescribed medications, attending cardiovascular follow-up appointments, and making recommended lifestyle changes are all meaningful steps toward reducing these risks over time. Patients should also learn the warning signs of brain stroke, which include sudden facial drooping, arm weakness, and difficulty speaking, and should seek emergency care immediately if any of these symptoms appear.
Sudden vision loss in one eye can be emotionally difficult and practically disorienting. Depth perception and peripheral awareness may be affected, which can influence activities such as driving, reading, and navigating unfamiliar spaces. Low vision rehabilitation, a specialized program designed to help people make the most of their remaining functional vision, can be a valuable resource for patients who experience lasting visual impairment. Emotional support through counseling or peer connection is also an important part of adjusting to this kind of sudden and significant change.
When to Seek Emergency Care
Recognizing the urgency of eye stroke symptoms can make a meaningful difference in outcome. The following guidance is intended to help patients and families know when and how to act without hesitation.
If you experience sudden, painless loss of vision in one eye, go to the nearest emergency department immediately or call emergency services. Do not wait to see if the vision returns on its own, and do not wait until the next available appointment with an eye care provider. Time is the single most important factor in determining whether any meaningful intervention is possible. Arriving quickly gives physicians the best opportunity to evaluate your situation and consider all available options.
If vision in one eye dims, darkens, or disappears for even a brief period and then returns to normal, seek emergency evaluation the same day. These transient episodes can be warning signs that a permanent and severe eye stroke is about to occur. Early evaluation allows physicians to identify the source of the problem and begin treatment that may prevent a more serious and lasting event from taking place.
Frequently Asked Questions
The following questions address common concerns that patients and families raise when navigating an eye stroke diagnosis or an emergency evaluation for sudden vision loss.
They are different events but share a closely related mechanism. Both involve arterial blockage that cuts off blood flow to sensitive tissue, and both can cause rapid and permanent damage. An eye stroke affects the retina, while a brain stroke affects brain tissue. The two conditions are linked because they are often driven by the same underlying cardiovascular disease. A person who has had an eye stroke carries a meaningfully elevated risk of brain stroke, which is why comprehensive stroke center evaluation and cardiovascular management are essential responses, not optional add-ons.
It is uncommon for both eyes to be affected simultaneously in embolus-related eye stroke. However, in conditions such as giant cell arteritis, bilateral involvement is possible if the condition goes unrecognized and untreated. Over time, the risk to the fellow eye is real in any form of retinal artery occlusion, particularly if the underlying cause has not been identified and treated. This is one of the key reasons that thorough systemic evaluation and ongoing follow-up care are so important after any episode of retinal artery occlusion.
The window for interventions aimed at restoring blood flow is measured in hours, not days. While the precise limit varies depending on the type of occlusion and individual factors, arriving within the first few hours of symptom onset provides the most options for evaluation and treatment. Even if you arrive outside the acute window, emergency evaluation is still necessary to assess brain stroke risk, identify the underlying cause, and begin cardiovascular treatment. The evaluation itself carries meaningful value at any point after symptom onset.
Yes. Ongoing care with a retina specialist is important after a retinal artery occlusion for several reasons. The affected eye can develop complications over time, including neovascularization, meaning the growth of abnormal new blood vessels driven by areas of chronic poor circulation. These complications can be treated effectively if detected early through regular monitoring. Your retina specialist will also coordinate with your primary care physician or cardiologist to help ensure that cardiovascular risk factors are being managed appropriately to protect both your vision and your overall vascular health.
Yes. Clinical research into acute retinal artery occlusion is ongoing, with several trials evaluating whether thrombolytic agents and other interventions can improve visual outcomes when given within the acute treatment window. New England Retina Associates is actively involved in clinical research and stays current on emerging evidence so that our patients have access to the most informed and up-to-date care options available. If you have questions about whether any investigational options might be relevant to your situation, we encourage you to bring them up during your visit with one of our physicians.
Expert Retina Care When It Matters Most
If you or a loved one has experienced sudden vision loss in one eye, please seek emergency care right away. New England Retina Associates is a retina-only practice with offices throughout Connecticut, and our fellowship-trained vitreoretinal surgeons have the specialized expertise to evaluate and manage retinal artery occlusion with the urgency and precision this condition demands. We welcome self-referred and emergency patients, and we are here to guide you through every step of care, from the initial emergency evaluation to long-term follow-up and support.
30 Years of Care & Commitment
